Dr. Martens plc
DOCMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $788 | $877 | $1,000 | $908 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Cost of Goods Sold | $276 | $374 | $436 | $366 |
| Gross Profit | $512 | $503 | $564 | $542 |
| % Margin | 65% | 57.3% | 56.4% | 59.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $377 | $373 | $309 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $456 | $0 | $0 | $0 |
| Operating Expenses | $456 | $377 | $373 | $309 |
| Operating Income | $56 | $126 | $191 | $233 |
| % Margin | 7.1% | 14.4% | 19.1% | 25.6% |
| Other Income/Exp. Net | -$47 | -$33 | -$86 | -$18 |
| Pre-Tax Income | $9 | $93 | $159 | $214 |
| Tax Expense | $4 | $24 | $31 | $33 |
| Net Income | $5 | $69 | $129 | $181 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -45.8% | -27.8% | – |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| Weighted Avg Shares Out | 962 | 984 | 1,001 | 1,000 |
| Weighted Avg Shares Out Dil | 974 | 986 | 1,001 | 1,003 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $2 | $0 |
| Interest Expense | $29 | $32 | $19 | $15 |
| Depreciation & Amortization | $73 | $72 | $54 | $37 |
| EBITDA | $111 | $196 | $204 | $266 |
| % Margin | 14% | 22.4% | 20.4% | 29.3% |